✦ LIBER ✦

705 Doxifluridine in patients with 5-FU resistant colorectal cancer

✍ Scribed by E. Bajetta; M. Di Bartolomeo; L. Somma; G. Vicario; L. Celio; P. Bignami; E. Bandieri; M. Baldini

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Doxifluridine in colorectal cancer patie

✍ E. Bajetta; M. Di Bartolomeo; L. Somma; M. Del Vecchio; S. Artale; F. Zunino; P. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 517 KB

Doxifluridine (5′-dFUrd) in patients wit

✍ Sophie D. Fosså; Olav Dahl; Roar Hoel; Mona Heier; Mitchell Loeb 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 266 KB

The pharmacokinetics of doxifluridine an

✍ L. J. Schaaf; B. R. Dobbs; I. R. Edwards; D. G. Perrier 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 671 KB

760 Methotrexate (MTX) and 5-fluorouraci

✍ P. Pronzato; F. Vaira; A. Viganni; P. Losardo; G. Bertelli 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Clinical activity and benefit of irinote

✍ E Van Cutsem; D Cunningham; W.W Ten Bokkel Huinink; C.J.A Punt; C.G Alexopoulos; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Factors predicting efficacy of oxaliplat

✍ Bensmaïne, M.A. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB